Tanaka Kuniya, Shimada Hiroshi, Nagano Yasuhiko, Endo Itaru, Sekido Hitoshi, Togo Shinji
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Surgery. 2006 Feb;139(2):263-73. doi: 10.1016/j.surg.2005.07.036.
We investigated the efficacy of microwave ablation plus hepatectomy for multiple bilobar colorectal metastases to the liver. No consensus exists concerning local ablation plus hepatic resection for treating multiple bilobar colorectal liver metastases, partly because of a lack of long-term comparative survival data.
Clinicopathologic data were analyzed retrospectively for 53 consecutive patients with 5 or more bilobar liver metastases from colorectal cancer who underwent hepatectomy with or without microwave ablation. Outcome measures were recurrence rate, recurrence pattern, and survival.
Combined resection/ablation was performed more frequently in patients with more liver metastases (P = .03). No significant differences were found for overall, disease-free, or hepatic recurrence-free survival between 16 patients with resection/ablation and 37 patients with resection (P = .43, .54, and .86, respectively). Multivariate analysis selected prehepatectomy carcinoembryonic antigen concentration in serum as an independent prognosticator for survival (P = .02), but not resection/ablation versus resection. In patients with combined resection/ablation, recurrence occurred near the resection or ablation line in only 2 patient (22%), whereas multiple neoplasms (>/=4) was the most common liver recurrence pattern (78%).
Microwave ablation plus hepatic resection expanded indications for operation to treat multiple bilobar liver metastases, with survival similar to that in less-involved hepatic resection patients.
我们研究了微波消融联合肝切除术治疗多叶性结直肠癌肝转移的疗效。对于局部消融联合肝切除术治疗多叶性结直肠癌肝转移,目前尚无共识,部分原因是缺乏长期的比较生存数据。
回顾性分析53例连续的结直肠癌肝转移患者的临床病理资料,这些患者有5个或更多的肝叶转移,接受了肝切除术,部分患者还接受了微波消融。观察指标为复发率、复发模式和生存率。
肝转移较多的患者更常进行联合切除/消融(P = 0.03)。16例接受切除/消融的患者与37例接受切除的患者在总生存、无病生存或无肝复发生存方面无显著差异(分别为P = 0.43、0.54和0.86)。多变量分析选择术前血清癌胚抗原浓度作为生存的独立预后因素(P = 0.02),但不是切除/消融与单纯切除的比较。在接受联合切除/消融的患者中,仅2例患者(22%)在切除或消融线附近复发,而多发肿瘤(≥4个)是最常见的肝复发模式(78%)。
微波消融联合肝切除术扩大了手术治疗多叶性肝转移的适应证,其生存率与肝转移较少患者接受肝切除术的生存率相似。